Hurlburt Elizabeth

SEC source: 0001213900-26-096385 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,463

SEC source: 0001213900-26-013407 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 278,539

F1 · price: Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person.

SEC source: 0001213900-26-008479 · ownership.xml · nonDerivative · entry 2

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,533

SEC source: 0001213900-26-008479 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,311

F1 · price: These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-26-005426 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,301

F1 · date: This transaction is being reported late due to an inadvertent administrative error.

SEC source: 0001213900-26-001938 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,095

SEC source: 0001213900-25-087013 · ownership.xml · derivative · entry 6

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 41,121 shares

Expires 2028-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones.

SEC source: 0001213900-25-087013 · ownership.xml · nonDerivative · entry 4

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,990

F2 · price: This transaction was executed in multiple trades at prices ranging from $12.98 to $13.17. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-25-087013 · ownership.xml · nonDerivative · entry 3

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-087013 · ownership.xml · derivative · entry 5

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,121

Underlying: Common Stock · 12,876 shares

Expires 2028-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones.

SEC source: 0001213900-25-087013 · ownership.xml · nonDerivative · entry 2

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,990

F1 · price: This transaction was executed in multiple trades at prices ranging from $13.50 to $13.61. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-25-087013 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-084129 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,414

F1 · price: These shares represent restricted stock units granted on 08/29/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vested 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-25-085282 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,990

F1 · balance_after: On September 3, 2025, the Reporting Person filed a Form 4 that omitted the Issuer's withholding of common stock to satisfy the tax liability obligation of the Reporting Person. As reported in this amendment, the Issuer withheld 8,424 shares of common stock to satisfy the tax liability obligation of the Reporting Person.

SEC source: 0001213900-25-003532 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,728

SEC source: 0001213900-25-001357 · ownership.xml · nonDerivative · entry 2

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,519

SEC source: 0001213900-25-001357 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,897

F1 · price: These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 13

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 25,000 shares

Expires 2034-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: These options were granted on 01/12/2024. These options vested 1/4 on the date of grant, and, subject to continued employment, will vest 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 12

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: These options were granted on 1/14/2023. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant and will vest 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 11

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,033

Underlying: Common Stock · 34,467 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 10

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,612

Underlying: Common Stock · 9,888 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 9

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,711

Underlying: Common Stock · 8,169 shares

Expires 2029-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted 1/10/2019 and vested as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 8

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,997

Underlying: Common Stock · 3 shares

Expires 2028-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones. This option was previously reported as covering 186,000 shares but was adjusted to reflect a reverse stock split that occurred on March 26, 2019.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 7

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,397

F1 · security: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · date: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · deemedExecutionDate: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · kind: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · shares: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · price: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · acquired: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · balance_after: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · ownership.direct: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · ownership.nature: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 6

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 5

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 4

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 3

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 2

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000929638-24-000134 · form4.xml · derivative · entry 3

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-01-11

F2 · derivative.exercise_date: These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000929638-24-000134 · form4.xml · nonDerivative · entry 2

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,397

SEC source: 0000929638-24-000134 · form4.xml · nonDerivative · entry 1

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,000

F1 · price: These restricted stock units ("RSUs") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-23-003552 · ownership.xml · derivative · entry 2

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2033-01-14

F1 · derivative.exercise_date: These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-22-008940 · doc4.xml · derivative · entry 2

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-02-18

F6 · derivative.exercise_date: These options were granted on 02/18/2022. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-21-029080 · ownership.xml · nonDerivative · entry 1

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: This transaction was executed in multiple trades at prices ranging from $6.665 to $6.97. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-21-002076 · doc4.xml · derivative · entry 2

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2031-01-11

F1 · derivative.exercise_date: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.

SEC source: 0001213900-20-012013 · doc4.xml · derivative · entry 3

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2030-05-11

F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-20-012013 · doc4.xml · derivative · entry 2

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2030-05-11

F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-20-004974 · doc4.xml · derivative · entry 2

Masson Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,764

Underlying: Common Stock · 24,764 shares

Expires 2030-02-25

F1 · derivative.exercise_date: These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001654954-19-000387 · section16.xml · derivative · entry 2

Masson Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2029-01-10

F1 · derivative.exercise_date: These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones.

SEC source: 0001654954-18-013655 · section16.xml · derivative · entry 2

Masson Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Stock · 40,000 shares

Expires 2028-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options vest as follows: 186,000 will vest over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vest on the achievement of certain milestones, subject to continued employment.

SEC source: 0001654954-18-013655 · section16.xml · nonDerivative · entry 1

Masson Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001654954-18-003745 · section16.xml · derivative · entry 1

Masson Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,000

Underlying: Common Stock · 310,000 shares

Expires 2028-03-19

F1 · derivative.exercise_date: The options vest as follows: 186,000 will vest over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining 124,000 options vest on the achievement of certain milestones, subject to continued employment.